163 related articles for article (PubMed ID: 34871777)
1. Increased glycolysis affects β-cell function and identity in aging and diabetes.
Murao N; Yokoi N; Takahashi H; Hayami T; Minami Y; Seino S
Mol Metab; 2022 Jan; 55():101414. PubMed ID: 34871777
[TBL] [Abstract][Full Text] [Related]
2. Metallothionein 1 negatively regulates glucose-stimulated insulin secretion and is differentially expressed in conditions of beta cell compensation and failure in mice and humans.
Bensellam M; Shi YC; Chan JY; Laybutt DR; Chae H; Abou-Samra M; Pappas EG; Thomas HE; Gilon P; Jonas JC
Diabetologia; 2019 Dec; 62(12):2273-2286. PubMed ID: 31624901
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of the malate-aspartate shuttle in mouse pancreatic islets abolishes glucagon secretion without affecting insulin secretion.
Stamenkovic JA; Andersson LE; Adriaenssens AE; Bagge A; Sharoyko VV; Gribble F; Reimann F; Wollheim CB; Mulder H; Spégel P
Biochem J; 2015 May; 468(1):49-63. PubMed ID: 25731850
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of Gjb4 impairs cell proliferation and insulin secretion in primary islet cells.
Gässler A; Quiclet C; Kluth O; Gottmann P; Schwerbel K; Helms A; Stadion M; Wilhelmi I; Jonas W; Ouni M; Mayer F; Spranger J; Schürmann A; Vogel H
Mol Metab; 2020 Nov; 41():101042. PubMed ID: 32565358
[TBL] [Abstract][Full Text] [Related]
5. Neuropeptide Y1 receptor antagonism protects β-cells and improves glycemic control in type 2 diabetes.
Yang CH; Ann-Onda D; Lin X; Fynch S; Nadarajah S; Pappas EG; Liu X; Scott JW; Oakhill JS; Galic S; Shi Y; Moreno-Asso A; Smith C; Loudovaris T; Levinger I; Eizirik DL; Laybutt DR; Herzog H; Thomas HE; Loh K
Mol Metab; 2022 Jan; 55():101413. PubMed ID: 34890851
[TBL] [Abstract][Full Text] [Related]
6. Elovl6 Deficiency Improves Glycemic Control in Diabetic
Zhao H; Matsuzaka T; Nakano Y; Motomura K; Tang N; Yokoo T; Okajima Y; Han SI; Takeuchi Y; Aita Y; Iwasaki H; Yatoh S; Suzuki H; Sekiya M; Yahagi N; Nakagawa Y; Sone H; Yamada N; Shimano H
Diabetes; 2017 Jul; 66(7):1833-1846. PubMed ID: 28461456
[TBL] [Abstract][Full Text] [Related]
7. Sirtuin 6 regulates glucose-stimulated insulin secretion in mouse pancreatic beta cells.
Xiong X; Wang G; Tao R; Wu P; Kono T; Li K; Ding WX; Tong X; Tersey SA; Harris RA; Mirmira RG; Evans-Molina C; Dong XC
Diabetologia; 2016 Jan; 59(1):151-160. PubMed ID: 26471901
[TBL] [Abstract][Full Text] [Related]
8. Imeglimin mitigates the accumulation of dysfunctional mitochondria to restore insulin secretion and suppress apoptosis of pancreatic β-cells from db/db mice.
Aoyagi K; Nishiwaki C; Nakamichi Y; Yamashita SI; Kanki T; Ohara-Imaizumi M
Sci Rep; 2024 Mar; 14(1):6178. PubMed ID: 38485716
[TBL] [Abstract][Full Text] [Related]
9. Role of NADH shuttle system in glucose-induced activation of mitochondrial metabolism and insulin secretion.
Eto K; Tsubamoto Y; Terauchi Y; Sugiyama T; Kishimoto T; Takahashi N; Yamauchi N; Kubota N; Murayama S; Aizawa T; Akanuma Y; Aizawa S; Kasai H; Yazaki Y; Kadowaki T
Science; 1999 Feb; 283(5404):981-5. PubMed ID: 9974390
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-124a is hyperexpressed in type 2 diabetic human pancreatic islets and negatively regulates insulin secretion.
Sebastiani G; Po A; Miele E; Ventriglia G; Ceccarelli E; Bugliani M; Marselli L; Marchetti P; Gulino A; Ferretti E; Dotta F
Acta Diabetol; 2015 Jun; 52(3):523-30. PubMed ID: 25408296
[TBL] [Abstract][Full Text] [Related]
11. Decreased IGF1R attenuates senescence and improves function in pancreatic β-cells.
Iwasaki K; Lalani B; Kahng J; Carapeto P; Sanjines S; Hela F; Abarca C; Tsuji T; Darcy J; Bartke A; Tseng YH; Kulkarni RN; Aguayo-Mazzucato C
Front Endocrinol (Lausanne); 2023; 14():1203534. PubMed ID: 37441495
[TBL] [Abstract][Full Text] [Related]
12. Pancreatic beta cells from db/db mice show cell-specific [Ca2+]i and NADH responses to glucose but not to alpha-ketoisocaproic acid.
Gustavsson N; Larsson-Nyrén G; Lindström P
Pancreas; 2005 Oct; 31(3):242-50. PubMed ID: 16163056
[TBL] [Abstract][Full Text] [Related]
13. EP3 signaling is decoupled from the regulation of glucose-stimulated insulin secretion in β-cells compensating for obesity and insulin resistance.
Schaid MD; Harrington JM; Kelly GM; Sdao SM; Merrins MJ; Kimple ME
Islets; 2023 Dec; 15(1):2223327. PubMed ID: 37415404
[TBL] [Abstract][Full Text] [Related]
14. Specific PERK inhibitors enhanced glucose-stimulated insulin secretion in a mouse model of type 2 diabetes.
Kim MJ; Kim MN; Min SH; Ham DS; Kim JW; Yoon KH; Park KS; Jung HS
Metabolism; 2019 Aug; 97():87-91. PubMed ID: 30615948
[TBL] [Abstract][Full Text] [Related]
15. Failure of the adaptive unfolded protein response in islets of obese mice is linked with abnormalities in β-cell gene expression and progression to diabetes.
Chan JY; Luzuriaga J; Bensellam M; Biden TJ; Laybutt DR
Diabetes; 2013 May; 62(5):1557-68. PubMed ID: 23274897
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of mitochondrial FAD-linked glycerol-3-phosphate dehydrogenase does not correct glucose-stimulated insulin secretion from diabetic GK rat pancreatic islets.
Ueda K; Tanizawa Y; Ishihara H; Kizuki N; Ohta Y; Matsutani A; Oka Y
Diabetologia; 1998 Jun; 41(6):649-53. PubMed ID: 9662045
[TBL] [Abstract][Full Text] [Related]
17. Metabolomic analyses reveal profound differences in glycolytic and tricarboxylic acid cycle metabolism in glucose-responsive and -unresponsive clonal β-cell lines.
Spégel P; Malmgren S; Sharoyko VV; Newsholme P; Koeck T; Mulder H
Biochem J; 2011 Apr; 435(1):277-84. PubMed ID: 21208194
[TBL] [Abstract][Full Text] [Related]
18. CNC-bZIP protein Nrf1-dependent regulation of glucose-stimulated insulin secretion.
Zheng H; Fu J; Xue P; Zhao R; Dong J; Liu D; Yamamoto M; Tong Q; Teng W; Qu W; Zhang Q; Andersen ME; Pi J
Antioxid Redox Signal; 2015 Apr; 22(10):819-31. PubMed ID: 25556857
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of miR-153, an IL-1β-responsive miRNA, prevents beta cell failure and inflammation-associated diabetes.
Sun Y; Zhou S; Shi Y; Zhou Y; Zhang Y; Liu K; Zhu Y; Han X
Metabolism; 2020 Oct; 111():154335. PubMed ID: 32795559
[TBL] [Abstract][Full Text] [Related]
20. CART is overexpressed in human type 2 diabetic islets and inhibits glucagon secretion and increases insulin secretion.
Abels M; Riva M; Bennet H; Ahlqvist E; Dyachok O; Nagaraj V; Shcherbina L; Fred RG; Poon W; Sörhede-Winzell M; Fadista J; Lindqvist A; Kask L; Sathanoori R; Dekker-Nitert M; Kuhar MJ; Ahrén B; Wollheim CB; Hansson O; Tengholm A; Fex M; Renström E; Groop L; Lyssenko V; Wierup N
Diabetologia; 2016 Sep; 59(9):1928-37. PubMed ID: 27338624
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
